DOI: https://doi.org/10.59321/BAUETJ.V4I2.1
AUTHOR(S)
Md. Jahid Hossain1*, Mst. Shagorika Shila2
ABSTRACT
Industry 4.0 is revolutionizing the pharmaceutical sector by integrating advanced technologies into manufacturing processes and supply chain management. Traditional approaches to manufacturing pharmaceuticals are being challenged and has undergone a significant transformation with the advent of the Fourth Industrial Revolution. This research aims to identify key factors influencing the adoption of Industry 4.0 technologies in Bangladesh’s pharmaceutical sector, the barriers they face, and provide insights to guide policy and strategic decisions for the development of this sector. In our research, we conducted a comprehensive investigation into 22 pharmaceutical companies in Bangladesh to assess their current adoption or willingness to adopt Pharma 4.0 technologies in manufacturing and validation processes. The study observed that approximately 55% of pharmaceutical companies are embracing Industry 4.0 technologies in their manufacturing process. Additionally, 50% of these companies have implemented automation in their warehouse operations and supply chain management tools. Moreover, investment by leading pharmaceutical companies in Pharma 4.0 adoption has shown a steady rise over the years. Overall, this study provides valuable insights into the landscape of pharmaceutical manufacturing in adopting Pharma 4.0 practices in pharmaceutical manufacturing which aligns with the Sustainable Development Goals (SDGs) and contributes to the vision of a SMART Bangladesh by 2041.